Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics Limited has submitted to the stock exchanges a routine compliance certificate under SEBI's Depositories and Participants Regulations. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime). It covers the quarter ended December 31, 2025, and confirms that all share dematerialisation requests received from depository participants during the quarter were properly verified, accepted or rejected, and the underlying physical certificates were cancelled. The certificate also confirms that the depository names were substituted as registered owners in the company's member register within the SEBI-prescribed timelines. The filing was signed by Managing Director Govardhan M. Dhoot.
This is a routine regulatory compliance filing with no material impact on the business, financials, or stock price. It simply reassures shareholders and exchanges that share demat activities for the October–December 2025 quarter were handled correctly by the RTA.